Old-Boy Network Alive, Poll Says

Date: December 15, 1986 WASHINGTON-Irregular funding and public ignorance are major problems facing scientists today, according to a survey of members of the scientific honor society Sigma Xi. The respondents believe that the distribution of government grants depends largely on "who you know" and that it is difficult for institutions lacking state-of-the-art equipment to obtain funds. The survey of more than 4,000 scientists in the United States and Canada was conducted by Sigma Xi as part of it

Written byVictoria Contie
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share


Date: December 15, 1986

WASHINGTON-Irregular funding and public ignorance are major problems facing scientists today, according to a survey of members of the scientific honor society Sigma Xi. The respondents believe that the distribution of government grants depends largely on "who you know" and that it is difficult for institutions lacking state-of-the-art equipment to obtain funds.

The survey of more than 4,000 scientists in the United States and Canada was conducted by Sigma Xi as part of its centennial celebration. The questionnaire was sent last spring to 10,000 active members of the 115,000-member society, which awards membership based on scientific research achievements.

A bare majority (51 percent) of the respondents are researchers in colleges or universities. Twenty-nine percent work in the private sector, and 15 percent in government labs. More than three-quarters hold doctoral degrees. By discipline, survey respondents mirror the distribution of the entire society: 27 percent from the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies